金达威：关于控股子公司取得兽药产品批准文号批件的公告

Core Viewpoint - Jindawei announced that its subsidiary, Jiangsu Chengxin Pharmaceutical Co., Ltd., has received a veterinary drug product approval number from the Ministry of Agriculture and Rural Affairs of the People's Republic of China [2] Group 1 - The approval signifies a regulatory milestone for the company in the veterinary pharmaceutical sector [2] - This development may enhance the company's product portfolio and market competitiveness [2] - The approval could lead to potential revenue growth from the veterinary drug market [2]